Literature DB >> 20471760

Prenatal diagnosis of trisomy 21 through detection of trophoblasts in cervical smears.

Stavros Sifakis1, Satish Ghatpande, Antti Seppo, Michael W Kilpatrick, Triantaphyllos Tafas, Petros Tsipouras, Moshe Fejgin, Aliza Amiel.   

Abstract

BACKGROUND: Fetal cells exfoliate in the uterine cavity during early pregnancy and are a potential source of material for NIPD. AIMS: This study was designed to test the hypothesis that fetal cells obtained from the uterine cervix during the first trimester of pregnancy could be utilized for prenatal diagnosis of chromosomal aneuploidy. STUDY
DESIGN: Fetal cells retrieved from the distal endocervical canal during the first trimester of pregnancy were hybridized with chromosome 21 specific FISH probes and analyzed with an automated fluorescence microscope. SUBJECTS AND OUTCOME MEASURES: Cells with 3 copies of chromosome 21 were detected in 5 out of 5 trisomy 21 pregnancies.
RESULTS: The number of trisomic cells detected ranged from 1 to 27 with a median value of 5.
CONCLUSIONS: FISH-based scanning can identify trisomy 21 pregnancies by analysis of routine cervical brushings. The approach offers the potential for non-invasive prenatal diagnosis as early as 5 weeks gestation. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20471760     DOI: 10.1016/j.earlhumdev.2010.04.005

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  3 in total

1.  Trophoblast retrieval and isolation from the cervix (TRIC) is unaffected by early gestational age or maternal obesity.

Authors:  Rani Fritz; Hamid Reza Kohan-Ghadr; Alex Sacher; Alan D Bolnick; Brian A Kilburn; Jay M Bolnick; Michael P Diamond; Sascha Drewlo; D Randall Armant
Journal:  Prenat Diagn       Date:  2015-09-20       Impact factor: 3.050

2.  Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications.

Authors:  Elisavet A Papageorgiou; Philippos C Patsalis
Journal:  Genome Med       Date:  2012-05-28       Impact factor: 11.117

Review 3.  Fetal Cell Based Prenatal Diagnosis: Perspectives on the Present and Future.

Authors:  Morris Fiddler
Journal:  J Clin Med       Date:  2014-09-05       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.